Michael A. Schade
Associate
mschade@dunlapcodding.com
(405) 607-8600
Michael A. Schade practices primarily in the area of intellectual property law, particularly in the area of patent prosecution. Michael’s expertise involves offering strategic intellectual property portfolio advice and prosecution to middle and large corporate clients, with a particular focus on chemical, biotechnology, and life science technologies.
Michael’s professional experience in the biotechnology and life science industries is diverse. Michael worked under the direction of Dr. Bruce Roe at the Advanced Center for Genome Technology, where his research involved the genomic sequencing of the thermophilic bacterium Bacillus stearothermophilus, as well as the first successful sequencing of human chromosome 22. Michael also worked for several years at the Oklahoma Medical Research Foundation, where he conducted neurogenetic analysis on the etiology of Alzheimer’s Disease. His research at the OMRF primarily centered on the proteins responsible for the synaptic signaling network in the nematode Caenorhabditis elegans.
Michael is a graduate of the University of Oklahoma College of Law. While attending law school, he clerked for the Honorable Judge Arlene Johnson on the Oklahoma Court of Criminal Appeals, as well as interning in the Organized Crime and Drug Enforcement Task Force within the U.S. Attorney’s Office for the Western District of Oklahoma. He also worked in the University of Oklahoma’s Office of Technology Development, where he conducted patentability analysis reports on a variety of inventions disclosed by University researchers.
Admissions:
Oklahoma
United States District Court for the Western District of Oklahoma
United States Patent and Trademark Office
Education:
University of Oklahoma, B.S., Biochemistry
University of Oklahoma School of Law, J.D.
Organizations:
American Bar Association—Intellectual Property Section
American Bar Association—Science and Technology Section
American Intellectual Property Law Association—Junior Member
Oklahoma Bar Association—Intellectual Property Section
Oklahoma Bar Association—Young Lawyers Division
Oklahoma Bar Association—Work, Life, Balance Standing Committee
American Chemical Society
Publications:
Nicole K. Charlie, Angela M. Thomure, Michael A. Schade, and Kenneth G. Miller. The Dunce cAMP Phosphodiesterase PDE-4 Negatively Regulates Gαs-Dependent and Gαs -Independent cAMP Pools in the Caenorhabditis elegans Synaptic Signaling Network. Genetics, Vol. 173, 111-130, May 2006.
Nicole K. Charlie, Michael A. Schade, Angela M. Thomure, and Kenneth G. Miller. Presynaptic UNC-31 (CAPS) Is Required to Activate the Gαs Pathway of the Caenorhabditis elegans Synaptic Signaling Network. Genetics, Vol.172, 943-961, Feb. 2006.
Michael A. Schade, Nicole K. Reynolds, Claudia M. Dollins, and Kenneth G. Miller. Mutations That Rescue the Paralysis of Caenorhabditis elegans ric-8 (Synembryn) Mutants Activate the Gαs Pathway and Define a Third Major Branch of the Synaptic Signaling Network. Genetics, Vol. 169, 631-649, Feb. 2005.
Nicole R. Reynolds, Michael A. Schade, and Kenneth G. Miller. Convergent, RIC-8-Dependent G? Signaling Pathways in the Caenorhabditis elegans Synaptic Signaling Network. Genetics, Vol. 169, 651-670, Feb. 2005.
